ドイツのトップ乳癌化学療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
5
ドイツ
レビュー
14000+
実際の患者より
トップ各国の乳癌化学療法価格を比較
国をタップしてトップ医師と価格を表示
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示：
Pfaffenbach教授は130本以上の論文を執筆しており、アカデミック病院ゾーリンゲンの消化器内科・腫瘍内科・内科部門を率いています。
ブール博士はドイツとヨーロッパで活動する著名な脳神経外科医であり、多くの科学論文の著者であり、様々な医学組織から賞賛と賞を受けています。
ブール博士は、椎間板病理（椎間板ヘルニア、変形性関節症、骨折など）、脳性麻痺、末梢神経系病理の治療における専門家として認められています。彼は悪性脳腫瘍、先天性および後天性血管異常の手術を行います。
医学実践の他にも、彼は活発に研究に従事しています。彼は医学博士であり、ヨーロッパの医学雑誌に彼の科学的な作品を発表しています。2016年には、神経病理学の問題に関する47の科学論文を発表しました。特に脳転移手術のテーマに関する彼の記事は非常に人気があります。
ブール博士は、頭蓋内のカーヴェルノーマの治療、脳転移に対する外科的治療および他の脳神経外科の領域に関する科学的な研究と研究を行っています。
ブール博士は、脳腫瘍の研究に専念する基金を共同設立しました。
ゾーリンゲンでのラルフ・ブール教授とブキメッドチーム
専門分野：
- 脳と脊髄の手術（コンピューター化されたニューロナビゲーション）
- 神経腫瘍学
- 血管病理
- 椎間板疾患：変形性関節症、椎間板ヘルニアおよび骨折。
- 末梢神経系の病理
- 最小侵襲手術、顕微手術および内視鏡手術
Dr. Walid Eljabu is triple board-certified in Plastic and Aesthetic Surgery, Hand Surgery, and Trauma Surgery. He has extensive experience in reconstructive and microsurgery. He trained in the UK and Germany, with additional specialist training in Sweden and Turkey. He is the CEO and Head Surgeon at Esthétique du Nord in Hamburg.
He specializes in facial rejuvenation (facelift, rhinoplasty), breast surgery, and body contouring. This includes inverse abdominoplasty.
Accreditation: MRCSEd (Royal College of Surgeons of Edinburgh). Memberships: Rhinoplasty Society of Europe; International Society of Aesthetic Plastic Surgery; German Society of Plastic, Reconstructive and Aesthetic Surgery; American Society of Plastic Surgeons; Royal College of Surgeons of Edinburgh; American Society for Surgery of the Hand; German Society of Hand Surgeons.
Prof. Dr. マルクス・ホイザーは、泌尿器科および小児泌尿器科の専門家であり、泌尿器がんの状態に焦点を当てています。彼の仕事は40以上の科学出版物を含んでいます。
この医師は、外傷学および小児外傷学、膝関節および股関節の人工関節置換術、緊急および再建手術、手の外科、集中治療、関節の変形性関節症の治療を専門としています。豊富な経験を持つ実践的な外科医として、ドイツとアメリカで研修を受け、上肢の外傷における国際的に認められた専門家であり、年間2,700人以上の患者を支援しています。
科学研究に積極的に取り組んでおり、手のマイクロサージェリーに関する論文を発表し、このトピックについて発表しています。この医師は、四肢のマイクロサージェリーに関するコンサルティングを世界中で行い、整形外科の専門家から世界的に認められています。
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Germanyの1022名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 34年の経験 | 乳癌化学療法 | 腫瘍学を専門とする診療科を統括し、豊富な研究実績を有する。130本以上の論文を執筆し、主要な欧州消化器病学会の会員である。 | ドイツ | から $250 |
Top oncologists for breast cancer chemotherapy in Germany include board-certified specialists at accredited cancer centers. These experts typically hold German Cancer Society certifications and participate in multidisciplinary tumor boards. Leading doctors like Dr. Viola Fox and Dr. Séverine Iborra integrate molecular diagnostics with personalized treatment protocols.
Bookimed Expert Insight: Data shows that choosing a dually qualified specialist often improves the patient journey. For example, Dr. Séverine Iborra in Solingen is a specialist in both gynecology and oncology. This combination allows one doctor to manage surgical diagnostics and chemotherapy protocols concurrently. Patients at these centers benefit from consolidated care without needing separate visits for imaging and treatment.
Patient Consensus: Patients emphasize that receiving a clear roadmap of the chemotherapy cycles and side-effect management is vital. Many found that large university hospitals offer the best coordination for pathology and imaging under one roof. They also noted that having English-speaking staff significantly reduces the stress of undergoing intensive treatment abroad.
Qualified breast cancer doctors in Germany must hold Facharzt certification in oncology or gynecology. You can verify their expertise by checking for associations with centers accredited by the German Cancer Society. Top specialists often lead multidisciplinary tumor boards to personalize chemotherapy protocols and manage complex cases.
Bookimed Expert Insight: German oncology structures prioritize interdisciplinary leadership. For example, Dr. Séverine Iborra at Solingen leads a specialized Senology center, while Prof. Boris Pfaffenbach heads an entire oncology department. This dual focus means your chemotherapy plan is overseen by a specialist who also manages the broader clinical department and participates in integrated tumor boards.
Patient Consensus: Patients note that well-qualified doctors often provide a written protocol immediately after the first consultation. They feel more confident when they see a multidisciplinary team, including surgeons and oncologists, collaborating on their specific case details. Many were relieved to find that reputable specialists encourage second opinions to confirm the best treatment path.
International patients can obtain independent second opinions from breast cancer specialists at leading German university hospitals. Board-certified oncologists provide these reviews through multidisciplinary tumor boards. They evaluate pathology reports and imaging to verify diagnoses. Remote consultations via video are frequently available for international cases.
Bookimed Expert Insight: Data shows that choosing specialists in academic centers like Bremen-Mitte or Solingen provides access to extensive research backgrounds. For instance, Prof. Boris Pfaffenbach has authored over 130 publications. This academic focus ensures patients receive opinions based on the latest clinical trials and innovative protocols. This is particularly valuable for rare or aggressive breast cancer subtypes.
Patient Consensus: Patients note that providing complete records is essential for a meaningful review. Many were relieved when specialists confirmed their current plans or refined treatment steps. They found that major clinics provide detailed written reports that are easy to share with local doctors.
German breast cancer specialists use both neoadjuvant and adjuvant chemotherapy based on individual tumor characteristics. Neoadjuvant therapy before surgery is favored for aggressive or large tumors to shrink them. This approach often allows for breast-conserving surgery instead of a full mastectomy.
Bookimed Expert Insight: German clinics like Academic Hospital Solingen and Nordwest Clinic utilize multidisciplinary boards to decide the chemotherapy sequence. Dr. Séverine Iborra at Solingen leads a dedicated breast clinic where molecular diagnostics guide these decisions. Data shows that German professors, such as Dr. Boris Pfaffenbach, often integrate extensive research into personalized protocols. This ensures the timing of chemotherapy aligns with the latest clinical findings for each specific cancer subtype.
Patient Consensus: Patients note that the treatment sequence feels like a collaborative decision between oncologists and surgeons. They appreciate that doctors explain how shrinking the tumor first can lead to less invasive surgery. Many felt reassured when their medical team adjusted the plan based on how the tumor responded to initial doses.
Breast cancer doctors in Germany use targeted therapies like HER2-inhibitors and CDK4/6 inhibitors alongside chemotherapy. Experts such as Dr. Viola Fox at Medical Center Solingen apply molecular diagnostics to select precise antibody-drug conjugates. This personalized approach often includes immunotherapy and specialized interventional radiology to improve outcomes.
Bookimed Expert Insight: German oncology centers stand out by staffing dual-qualified specialists. For instance, Dr. Viola Fox holds certifications in both oncology and genetics. This allows clinics to integrate molecular tumor boards directly into the treatment planning phase. Patients benefit from real-time genomic insights that determine if they qualify for the latest clinical trials.
Patient Consensus: Patients find that treatment plans are strictly driven by detailed pathology results like HER2 and BRCA status. Many note the frequency of neoadjuvant therapy, which combines targeted drugs with chemotherapy to shrink tumors before surgery. They emphasize feeling reassured by the highly protocolized nature of German cancer centers.